We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Regulators Approve Merger Between Teva, Ivax
European Regulators Approve Merger Between Teva, Ivax
November 29, 2005
The European Commission has approved Teva Pharmaceutical's bid to buy U.S. drug firm Ivax for $7.4 billion, bringing Teva one step closer to reclaiming its title as the world's largest generic drugmaker.